There's a new layer of drug-industry middlemen that could drive up costs for patients

Advertisement
There's a new layer of drug-industry middlemen that could drive up costs for patients
Crystal Cox/Business Insider

Hello,

Advertisement

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...


Powerful drug-industry middlemen have quietly launched businesses to get better deals from drugmakers. It could drive up costs for patients.

Read our deep dive>>


There's a new layer of drug-industry middlemen that could drive up costs for patients
Beam Therapeutics cofounder David Liu.Jessica Rinaldi/The Boston Globe via Getty Images
As gene-editing moves mainstream, a pioneer in the field is testing whether it could prevent Alzheimer's

Check it out>>

Advertisement


There's a new layer of drug-industry middlemen that could drive up costs for patients
Patient and doctor.Halfpoint / Getty Images
We asked major health systems to share the promising tech projects they are testing at hospitals. Here are 8 that are taking off.

See more>>


More stories we're reading:


-Leah

{{}}